BUPLANT
associated with 34 other trademarks
Pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained releas...

Words that describe this trademark:

implantable drug delivery  drug delivery system  delivery system  primarily  formulation  comprised  matrix  system  pharmaceuticals  subdermal 

Serial Number:

85734080

Mark:

BUPLANT

Status:

Abandoned-No Statement of Use filed

Status Date:

05-30-2016

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction and pain management; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

02-26-2013

Mark Drawing Status:

Standart Character Mark

Abandon Date:

05-30-2016

Business Name:

MORRISON & FOERSTER LLP

Correspondent Name:

Recent Trademark filings by this company